TOVX

Theriva Biologics Inc

$0.24

-0.01 (-4.78%)

Analyst Overview

Target Price:

Date: 15.04.2026

$2.50

(+937.34%)

Strong Buy: 0

Buy: 1

Hold: 1

Sell: 0

Strong Sell: 0

Description:

Theriva Biologics Inc., a clinical-stage company, develops therapies to treat diseases in areas of high unmet need. The company is headquartered in Rockville, Maryland.

Exchange:

NYSE MKT

Country:

USA

Sector:

HEALTHCARE

Industry:

BIOTECHNOLOGY

Address:

9605 MEDICAL CENTER DRIVE, ROCKVILLE, MD, UNITED STATES, 20850

Fiscal year end:

December

Market capitalization:

$11.6 Million

EBITDA:

-$14.9 Million

PERatio:

0.0

EPS:

-2.08

Dividend per share:

$0.00

Dividend yield:

0.0%

Beta:

0.471

Dividends for 10 years

Income Statements for 10 years

Earnings calender

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:

$1,000

How much will you earn in 10 years:

-100%

How much will you get:

Prices dates:

31-03-2016: $20,650.00 and 31-03-2026: $0.20